Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS safely and effectively. See full prescribing information for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE TABLETS. ABACAVIR, LAMIVUDINE and ZIDOVUDINE tablets, for oral useInitial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Abacavir, lamivudine and zidovudine tablet is indicated in combination with other antiretrovirals or alone for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: Limited data exist on the use of abacavir, lamivudine and zidovudine tablets alone in patients with higher baseline viral load levels (greater than 100,000 copies per mL) [see CLINICAL STUDIES (14)] .
- generic_name
- abacavir , lamivudine and zidovudine
- product_names
- ABACAVIR , LAMIVUDINE AND ZIDOVUDINE
- ndc
- 68180-286, 68180-286-07, 68180-286-01, 68180-286-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en